Acute chest pain (ACP) is a common symptom that presents in a variety of clinical settings. Its broad differential diagnoses, ranging from benign to life-threatening conditions, necessitate a systematic diagnostic approach. This article aims to provide a comprehensive guide to evaluating ACP in clinical practice.
The initial assessment should focus on identifying life-threatening conditions, such as acute coronary syndrome (ACS), aortic dissection, and pulmonary embolism. A thorough history, physical examination, and 12-lead ECG are essential. High-risk features such as radiating pain, associated symptoms, and risk factors for cardiovascular disease should raise suspicion for ACS.
Following the initial assessment, further diagnostic testing may be required. Cardiac biomarkers, such as troponin, provide valuable information about myocardial injury. Imaging studies, like chest X-ray or CT angiography, can help diagnose other causes of ACP. However, these tests should be used judiciously, considering their risks and benefits.
Risk stratification is crucial in determining the disposition of patients with ACP. Several risk scores, including the HEART and GRACE scores, can be used to predict the risk of major adverse cardiac events. These scores can guide decisions regarding hospital admission and further testing.
Shared decision making is an important aspect of evaluating ACP. After discussing the diagnostic findings, potential risks, and management options, the clinician and patient can collaboratively make informed decisions about further management.
Evaluating ACP requires a systematic approach, including initial assessment, diagnostic testing, risk stratification, and shared decision making. By following these steps, clinicians can ensure a comprehensive evaluation of ACP, facilitating appropriate and timely management of this common clinical presentation.
1.
Make the Diagnosis: Can You Explain Her Rash and Conjunctival Injection?
2.
Should the UK introduce targeted prostate cancer screening? The case for and against
3.
Real-World EV Plus Pembro Success Seen in Urothelial Cancer
4.
In a clinical trial, "3D mammography" nearly reduces the incidence of breast cancer between two screening exams.
5.
Investigating the Relationship Between GERD and Anxiety/Depression.
1.
Building Physical Resilience in Chronic Blood Disorders
2.
Can AI Become Our Oncologic Ally? A Look at Artificial Intelligence in Cancer Detection and Control
3.
Artificial Intelligence for Spatial Tumor Evolution Reconstruction
4.
What are Acanthocytes? Understanding the Role of Spiky Red Blood Cells
5.
Harnessing Cuproptosis: A Novel Nanomedicine Strategy for Triple-Negative Breast Cancer
1.
International Conference on Oncology, Cardiology and Critical Care Policy
2.
International Conference on Innovations in Critical Care for Oncology and Cardiology
3.
International Conference on Oncology, Cancer Prevention and Public Health
4.
International Conference on Cancer Nursing and Rehabilitation Strategies
5.
International Conference on Cancer Nursing and Hematology Support
1.
Management of 1st line ALK+ mNSCLC (CROWN TRIAL Update) - Part V
2.
Understanding Risk Factors Associated With Common Cancers
3.
Evolving Space of First-Line Treatment for Urothelial Carcinoma- Case Discussion
4.
An In-Depth Look At The Signs And Symptoms Of Lymphoma- The Conclusion
5.
The Role of Hemoglobin in Maintaining Healthy Oxygen Levels
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation